Industry news and announcements for people in the clinical trials industry.
VirtualScopics, Inc. (Rochester, NY) announced that Barbara Ulrich has joined the company as Director of Human Resources.
Camargo Pharmaceutical Services (Cincinnati, OH) expanded its leadership team and therapeutic experience with the appointment of Steven A. Castillo as Vice President of Drug Development.
CTI Clinical Trial and Consulting Services (Cincinnati, OH) announces the following new hires: Caitrin Cardosi hired as Business Development Associate; Larry Gache hired as Programmer/Statistician; Teri Maraan hired as Associate Study Manager; Molly McKean hired as Assistant Project Manager; Sally Kirsh hired as Associate Study Manager; Nimra Tariq hired as Biostatistician I. They also announced the following promotions: Michelle Cosgrove promoted to Associate Study Manager; Gideon Devadason promoted to Senior Statistical Programmer; Ryan Gifford promoted to Assistant Director, Business Development and Client Management; Nick Schatzman promoted to Assistant Project Manager.
Mapi (Yardley, PA) strengthens its North American team with the appointment of Charles Makin as Vice President, HEOR and Strategic Market Access.
Theorem Clinical Research (King of Prussia, PA) has named Kathryn Bohannon as Vice President of Biopharmaceutical Development, and Angela Weston as Vice President of Business Development in Europe and Asia.
Clinverse, Inc. (Durham, NC) announced the addition of John Musante as Chief Commercial Officer.
Medical Research Network (Skokie, IL and Milton Keynes, UK) has cemented its growth in Europe and the US after hiring two more professionals on either side of the Atlantic. Yvonne Pella joins MRN as Vendor Contracts Associate in the company's Skokie, IL office in the US, whilst Yasmine Alam joins MRN as a Project Manager at its UK headquarters in Milton Keynes.
Covance (Princeton, NJ) announced that it has been awarded the 2014 Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award, based on the company’s strong business performance and continued investments in the Asia Pacific region.
ERT (Philadelphia, PA) announced that it has been honored as a 2014 Innovation Award Recipient by the Philadelphia Business Journal. The awards program recognizes the region’s leading companies for their innovations in the fields of healthcare and life sciences.
CluePoints (Cambridge, MA) has secured an ENTENTE Life Science Investment Forum Award. The award program, which is organized by the ENTENTE project and supported by the European Commission and EuropaBio, recognized CluePoints as one of Belgium's most innovative high technology businesses for its Central Statistical Monitoring (CSM) solution that employs unique statistical algorithms to determine the quality, accuracy and integrity of clinical trial data.
Greenphire (King of Prussia, PA) has won a place in Deloitte's 2014 Technology Fast 500. Ranking 48th in the annual list of the fastest growing technology companies in the U.S, Greenphire secured its place as a result of an exceptional 2782% growth over the past four years.
ICON Firecrest (Dublin, Ireland) received a 2014 Global Award for its art and technique: animation entry, “Firecrest Through the Body.” This 3D animated video was created and developed by a team of 3D graphic designers and pharmacologists at Firecrest. It features realistic views of systems inside the body and it showcases the diverse range of medical areas in which Firecrest has expertise. Firecrest’s 3D animations are used to supplement study-specific training programs that have been proven to reinforce study consistency, quality and compliance.
CRF Health (Plymouth Meeting, PA) announced that it ranked 354th in the 2014 Deloitte Fast 500, marking the third year in a row that the company has been included in the annual list of the fastest growing technology organizations in North America. The company was recognized for its exceptional 231% revenue growth from 2009-2013.
Pharmaceutical Product Development, LLC (Wilmington, NC) nnounced that Randy Anderson, PhD, Vice President of Global Product Development and Therapeutic Area Leader for Metabolics, was named a 2014 Health Care Hero. The annual awards honor members of the greater Wilmington medical community for their engagement on critical health issues.
Chiltern (London, UK and Wilmington, NC) has been recognized by the Triangle Business Journal as one of the fastest growing private companies in the Research Triangle Park area.
LabConnect, LLC, (Seattle, WA) a leading provider of central laboratory services to the biopharmaceutical industry, is listed as one of the fastest-growing private companies by the Deloitte Technology Fast 500, the Puget Sound Business Journal (PSBJ) and Inc. 5000.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.